
GSK vs LPCN
$GSK vs $LPCN head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GSK vs LPCN: the quick read
- ·GSK is the larger company by market cap ($95.11B vs $18M).
- ·GSK has been more active on our scanner (71 vs 39 alerts in 30 days).
- ·LPCN has the smaller float (7.9M vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·They trade in different worlds by share price: LPCN is a low-priced stock where a few cents is a real percentage move, while the other is priced for steadier increments.
- ·Both stay busy on our scanner, 71 and 39 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are not really peers by size: GSK is more than 5244x the market cap of LPCN, so the same dollar of news moves LPCN far harder.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
- ·GSK pays a dividend and LPCN does not, which usually means one is being held for income and the other for the move.
- ·LPCN is the one in play today, trading about 2899x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GSK and LPCN on TheDesperateTrader.
- Is GSK or LPCN the better stock?
- "Better" depends on your goal, and these two are not alike. GSK is the larger company by market cap ($95.11B vs $18M). GSK has been more active on our scanner (71 vs 39 alerts in 30 days). LPCN has the smaller float (7.9M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GSK and LPCN?
- The differences that matter: GSK is roughly 5244x the size of the other by market cap ($95.11B vs $18M); they trade at very different share prices ($46.32 vs $2.01); GSK sits at 18% of its 52-week range against 2% for LPCN; only GSK pays a dividend; our scanner flagged GSK 71 times in the last 30 days against 39 for LPCN. Everything above is measured from the latest completed session and SEC filings.
- Which of GSK and LPCN is more active right now?
- Right now GSK is at about 1.7x its normal volume and LPCN is at about 2899.1x, so LPCN is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GSK or LPCN? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore GSK and LPCN comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.